[Interactions of antitubercular drugs. II. Combined effects of rifampin, ethambutol, capreomycin, viomycin, ethionamide and cycloserine on mycobacterial growth in vitro].
D000995:Antitubercular Agents / Q000494:pharmacology*; D002207:Capreomycin / Q000494:pharmacology; D003523:Cycloserine / Q000494:pharmacology; D004357:Drug Synergism; D004977:Ethambutol / Q000494:pharmacology; D005000:Ethionamide / Q000494:pharmacology; D066298:In Vitro Techniques; D009161:Mycobacterium / Q000187:drug effects* / Q000254:growth & development; D012293:Rifampin / Q000494:pharmacology; D014756:Viomycin / Q000494:pharmacology
D000995:Antitubercular Agents; D002207:Capreomycin; D004977:Ethambutol; D003523:Cycloserine; D005000:Ethionamide; D012293:Rifampin; D014756:Viomycin
Interakcja leków przeciwpratkowych. II. Skojarzone działanie rifampicyny z etambutolem, kapreomycyna, wiomycyna, etionamidem i cykloseryna na wzrost szczepów mykobakterii w badaniach in vitro.